MoneyWorks4Me

Cipla informs about analyst meet

06 Jun 2019 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that it has enclosed the schedule of analyst / institutional investor meetings.

The above information is a part of company’s filings submitted to BSE.








Peers
Company Name CMP
Sun Pharma. Inds. 1843.80
Dr. Reddys Labs. 1235.80
Cipla 1389.60
Lupin 2075.00
Zydus Lifesciences 1217.75
View more..